Notifications can be managed in browser preferences.Jump to contentIndependentSwipe for next articleIndependent Bulletin homepageDownload our appAllNewsSportCultureLifestyleJane KirbyThursday 30 April 2026 02:20 BSTLeukaemia sufferer finds donorA Great Ormond Street Hospital (Gosh) study has found a gentler treatment for children with relapsed leukaemia, potentially boosting survival and quality of life.The UKALL Rel2020 study, involving 188 children, demonstrated that less intensive chemotherapy followed by blinatumomab (a targeted immunotherapy) is safe and effective.The new approach achieved a 92 per cent remission rate and an 82 per cent long-term survival rate after three years, comparable to more intensive traditional treatments.Crucially, no patients died during the early phase of treatment, a significant improvement over traditional methods that carried substantial risks.The clinical trial was delivered as routine NHS care, making its results highly representative of real-world patient outcomes for acute lymphoblastic leukaemia (ALL).In fullLeukaemia treatment could boost survival and quality of life – Great Ormond StThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in